{
    "clinical_study": {
        "@rank": "90947", 
        "brief_summary": {
            "textblock": "OBJECTIVES: I. Determine the prevalence of glucocorticoid-remediable aldosteronism (GRA) in\n      various hypertensive populations and screen at risk members of GRA pedigrees.\n\n      II. Investigate other factors regulating blood pressure in GRA (environmental, genetically\n      determined factors).\n\n      III. Investigate renal and hormonal mechanisms regulating potassium homeostasis in GRA.\n\n      IV. Describe clinical phenotype of GRA patients. V. Prospectively screen GRA-affected\n      patients with MRI angiography for intracranial aneurysm."
        }, 
        "brief_title": "Study of Prevalence and Clinical Phenotype in Patients With Glucocorticoid-Remediable Aldosteronism", 
        "condition": "Hyperaldosteronism", 
        "condition_browse": {
            "mesh_term": "Hyperaldosteronism"
        }, 
        "detailed_description": {
            "textblock": "PROTOCOL OUTLINE:\n\n      Patients are screened for high blood pressure, suppressed plasma renin activity level, and\n      low potassium levels.  Urine is collected for a 24 hour period. Blood specimen is collected\n      for molecular biologic evaluation for the presence of the chimeric gene diagnostic of GRA.\n      Any history of cardiovascular events is recorded."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "PROTOCOL ENTRY CRITERIA:\n\n        --Disease Characteristics-- Diagnosed glucocorticoid-remediable aldosteronism (GRA) with\n        hypertension Hypokalemia is variably seen Blood pressure variably elevated Elevated level\n        of aldosterone Low level of plasma renin activity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "firstreceived_date": "October 18, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004354", 
            "org_study_id": "199/11917", 
            "secondary_id": "BWH-91328603"
        }, 
        "intervention_browse": {
            "mesh_term": "Glucocorticoids"
        }, 
        "keyword": [
            "endocrine disorders", 
            "genetic diseases and dysmorphic syndromes", 
            "hyperaldosteronism", 
            "rare disease"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02115"
                }, 
                "name": "Brigham and Women's Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "overall_official": {
            "affiliation": "Brigham and Women's Hospital", 
            "last_name": "Robert G. Dluhy", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004354"
        }, 
        "source": "National Center for Research Resources (NCRR)", 
        "sponsors": {
            "collaborator": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "National Center for Research Resources (NCRR)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "June 1999", 
        "study_design": "Primary Purpose: Screening", 
        "study_type": "Observational", 
        "verification_date": "May 2002"
    }, 
    "geocoordinates": {
        "Brigham and Women's Hospital": "42.358 -71.06"
    }
}